PHASE III CLINICAL TRIALS

PRESS RELEASE

May 11, 2011

Dr. Parkash Gill today announced that Veglin is not available until receiving further FDA approval. This delay is considered normal and a required process by the FDA. Once the FDA aproves, Alimta Cisplatin chemotherapy along with Veglin (a non-chemotherapy) will be the next protocol used.

 

ASK DR. GILL - ONCOLOGIST

Are you interested in trying a Clinical Trial?
Do you have questions related to malignant mesothelioma?

Dr. Gill and questions about mesothelioma treatment trials.
Dr. Parkash S. Gill is a professor of Medicine and Pathology and leads our trials team.

 

To answer these questions please use this form to send a request. Dr. Gill will make a reply by return e-mail.

Please allow some time for him to respond, depending on his schedule and the volume of questions this can take a few hours or days.

Compose your question for Dr. Gill here:

*required information

Contact Name:*
Email Address:*
Phone Number:*
Subject:
Message:*

Email Copy - Select to receive a copy of the submitted form.

To eliminate form spam and hijacking by automated bots we use Human Intelligence Identification. For your form to be submitted please answer the following question before you submit the form. The question MUST be answered in lower case.
What is the fifth letter of the alphabet?